Details for New Drug Application (NDA): 206918
✉ Email this page to a colleague
NDA 206918 describes FONDAPARINUX SODIUM, which is a drug marketed by Dr Reddys Labs Ltd, Eugia Pharma, Hangzhou Zhongmei, Hengrui Pharma, and Scinopharm Taiwan, and is included in five NDAs. It is available from six suppliers. Additional details are available on the FONDAPARINUX SODIUM profile page.
The generic ingredient in FONDAPARINUX SODIUM is fondaparinux sodium. There are fourteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the fondaparinux sodium profile page.
The generic ingredient in FONDAPARINUX SODIUM is fondaparinux sodium. There are fourteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the fondaparinux sodium profile page.
Summary for 206918
| Tradename: | FONDAPARINUX SODIUM |
| Applicant: | Eugia Pharma |
| Ingredient: | fondaparinux sodium |
| Patents: | 0 |
Pharmacology for NDA: 206918
| Mechanism of Action | Factor Xa Inhibitors |
Suppliers and Packaging for NDA: 206918
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| FONDAPARINUX SODIUM | fondaparinux sodium | INJECTABLE;SUBCUTANEOUS | 206918 | ANDA | Eugia US LLC | 55150-230 | 55150-230-02 | 2 SYRINGE, GLASS in 1 CARTON (55150-230-02) / .5 mL in 1 SYRINGE, GLASS (55150-230-00) |
| FONDAPARINUX SODIUM | fondaparinux sodium | INJECTABLE;SUBCUTANEOUS | 206918 | ANDA | Eugia US LLC | 55150-230 | 55150-230-10 | 10 SYRINGE, GLASS in 1 CARTON (55150-230-10) / .5 mL in 1 SYRINGE, GLASS (55150-230-00) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;SUBCUTANEOUS | Strength | 2.5MG/0.5ML | ||||
| Approval Date: | Dec 26, 2017 | TE: | AP | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;SUBCUTANEOUS | Strength | 5MG/0.4ML | ||||
| Approval Date: | Dec 26, 2017 | TE: | AP | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;SUBCUTANEOUS | Strength | 7.5MG/0.6ML | ||||
| Approval Date: | Dec 26, 2017 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
